These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Metabolic and nutritional complications of specific support measures in malignant hemopathies]. Gandarillas MA; Conde E; de las Heras G; Bello C; Richard C; Iriondo A; Garijo J; Zubizarreta A Sangre (Barc); 1985; 30(4-B):578-610. PubMed ID: 3909468 [No Abstract] [Full Text] [Related]
48. [Head nurse Tove Geisler, Finsen Institute: oncological nursing is different on account of its complexity. Interview by Inger Rosenkvist]. Geisler T Sygeplejersken; 1981 Sep; 81(35):4-6. PubMed ID: 6913228 [No Abstract] [Full Text] [Related]
49. The role of the i.v. specialist in health care reform. Robertson KJ J Intraven Nurs; 1995; 18(3):130-44. PubMed ID: 7776068 [TBL] [Abstract][Full Text] [Related]
50. The benefits of providing chemotherapy at home. Watters C Prof Nurse; 1997 Feb; 12(5):367-70. PubMed ID: 9128691 [TBL] [Abstract][Full Text] [Related]
51. Ethical dilemmas in intravenous nursing: a problem-solving model. Zonderman A J Intraven Nurs; 1994; 17(1):12-9. PubMed ID: 8138857 [TBL] [Abstract][Full Text] [Related]
52. [How to install an implantable site for chemotherapy through the cephalic vein]. Leblanc E Gynecol Obstet Fertil; 2005 Mar; 33(3):159-60. PubMed ID: 15848090 [No Abstract] [Full Text] [Related]
53. Infusion nurses society position paper. Administration of antineoplastic agents. J Infus Nurs; 2002; 25(2):83-5. PubMed ID: 11984221 [TBL] [Abstract][Full Text] [Related]
54. Changing i.v.s: kids are different. Harrington L Nursing; 2007 Sep; 37(9):6. PubMed ID: 17728617 [No Abstract] [Full Text] [Related]
55. Metabolic complications of induction therapy for leukemia and lymphoma. Cohen DG Cancer Nurs; 1983 Aug; 6(4):307-10. PubMed ID: 6554111 [No Abstract] [Full Text] [Related]
56. Chemotherapy-handling practices of outpatient and office-based oncology nurses. Martin S; Larson E Oncol Nurs Forum; 2003; 30(4):575-81. PubMed ID: 12861318 [TBL] [Abstract][Full Text] [Related]
57. Overview of biotherapy and nursing considerations. Coleman C J Intraven Nurs; 1998; 21(6):367-73. PubMed ID: 10392103 [TBL] [Abstract][Full Text] [Related]
58. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report. Dahabreh I; Tsoutsos G; Tseligas D; Janinis D BMC Clin Pharmacol; 2006 Sep; 6():5. PubMed ID: 16968538 [TBL] [Abstract][Full Text] [Related]